Shi NQ - Search Results

1

"Felodipine-indomethacin" co-amorphous supersaturating drug delivery systems: "Spring-parachute" process, stability, in vivo bioavailability, and underlying molecular mechanisms.

Li YW, Zhang HM, Cui BJ, Hao CY, Zhu HY, Guan J, Wang D, Jin Y, Feng B, Cai JH, Qi XR, Shi NQ. Li YW, et al. Among authors: shi nq. Eur J Pharm Biopharm. 2021 Sep;166:111-125. doi: 10.1016/j.ejpb.2021.05.030. Epub 2021 Jun 10. Eur J Pharm Biopharm. 2021. PMID: 34119671

2

Distinct transduction modes of arginine-rich cell-penetrating peptides for cargo delivery into tumor cells.

Ma DX, Shi NQ, Qi XR. Ma DX, et al. Among authors: shi nq. Int J Pharm. 2011 Oct 31;419(1-2):200-8. doi: 10.1016/j.ijpharm.2011.08.001. Epub 2011 Aug 9. Int J Pharm. 2011. PMID: 21843610

3

Enhancing cellular uptake of activable cell-penetrating peptide-doxorubicin conjugate by enzymatic cleavage.

Shi NQ, Gao W, Xiang B, Qi XR. Shi NQ, et al. Int J Nanomedicine. 2012;7:1613-21. doi: 10.2147/IJN.S30104. Epub 2012 Mar 26. Int J Nanomedicine. 2012. PMID: 22619516 Free PMC article.

4

PSA-responsive and PSMA-mediated multifunctional liposomes for targeted therapy of prostate cancer.

Xiang B, Dong DW, Shi NQ, Gao W, Yang ZZ, Cui Y, Cao DY, Qi XR. Xiang B, et al. Among authors: shi nq. Biomaterials. 2013 Sep;34(28):6976-91. doi: 10.1016/j.biomaterials.2013.05.055. Epub 2013 Jun 15. Biomaterials. 2013. PMID: 23777916

5

[The development of co-amorphous drug systems].

Yao J, Shi NQ, Wang XL. Yao J, et al. Among authors: shi nq. Yao Xue Xue Bao. 2013 May;48(5):648-54. Yao Xue Xue Bao. 2013. PMID: 23888685 Review. Chinese.

6

Deoxycholic acid-grafted PEGylated chitosan micelles for the delivery of mitomycin C.

Zhang XR, Shi NQ, Zhao Y, Zhu HY, Guan J, Jin Y. Zhang XR, et al. Among authors: shi nq. Drug Dev Ind Pharm. 2015 Jun;41(6):916-26. doi: 10.3109/03639045.2014.913613. Epub 2014 Apr 30. Drug Dev Ind Pharm. 2015. PMID: 24785368

7

A survey on "Trojan Horse" peptides: opportunities, issues and controlled entry to "Troy".

Shi NQ, Qi XR, Xiang B, Zhang Y. Shi NQ, et al. J Control Release. 2014 Nov 28;194:53-70. doi: 10.1016/j.jconrel.2014.08.014. Epub 2014 Aug 23. J Control Release. 2014. PMID: 25151981 Review.

8

Targeting and microenvironment-responsive lipid nanocarrier for the enhancement of tumor cell recognition and therapeutic efficiency.

Gao W, Meng T, Shi N, Zhuang H, Yang Z, Qi X. Gao W, et al. Adv Healthc Mater. 2015 Apr 2;4(5):748-59. doi: 10.1002/adhm.201400675. Epub 2014 Dec 17. Adv Healthc Mater. 2015. PMID: 25522298

9

On the inherent properties of Soluplus and its application in ibuprofen solid dispersions generated by microwave-quench cooling technology.

Shi NQ, Lai HW, Zhang Y, Feng B, Xiao X, Zhang HM, Li ZQ, Qi XR. Shi NQ, et al. Pharm Dev Technol. 2018 Jul;23(6):573-586. doi: 10.1080/10837450.2016.1256409. Epub 2016 Nov 16. Pharm Dev Technol. 2018. PMID: 27824281

10

Taming the Wildness of "Trojan-Horse" Peptides by Charge-Guided Masking and Protease-Triggered Demasking for the Controlled Delivery of Antitumor Agents.

Shi NQ, Qi XR. Shi NQ, et al. ACS Appl Mater Interfaces. 2017 Mar 29;9(12):10519-10529. doi: 10.1021/acsami.7b01056. Epub 2017 Mar 14. ACS Appl Mater Interfaces. 2017. PMID: 28290666

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters